stockrow
Saturday 7 November 2026
Export CCEL’s income statement to Excel — free account
Cryo-Cell International Inc.
CCEL Healthcare Medical Care Facilities
Cryo-Cell International Inc.’s revenue for fiscal 2025 (year ended November 2025) was $31.6 million, down 1.31% from fiscal 2024.
- Revenue
- −0.02%
- EPS
- +77.8%
- Free cash flow
- −58.4%
- Total debt
- −29.5%
Quarter to August 2026, against a year earlier
4.97
0.02
+0.40%
Follow CCEL
Alert me
Cryo-Cell International Inc. (CCEL) P/E ratio
Cryo-Cell International Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 790× (February 2025) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 171× | — |
| FY2023 | 0.0× | — |
| FY2022 | 12.9× | (73.01%) |
| FY2021 | 47.6× | 198.39% |
| FY2020 | 16.0× | (39.36%) |
| FY2019 | 26.3× | — |
| FY2018 | 0.0× | — |
| FY2017 | 24.4× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Aug 2026 | 0.0× | — |
| May 2026 | 0.0× | — |
| Feb 2026 | 0.0× | — |
| Nov 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
Low 0.0×
High 790×
Ten-year median
14.3×
Current reading's percentile
37
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| DCGO DocGo Inc. compare | n/m |
| PARK Park Dental Partners, Inc. compare | n/m |
| CCM Concord Medical Services Holdings Limited compare | n/m |
| AIRS AirSculpt Technologies, Inc. compare | n/m |
| PIII P3 Health Partners Inc. compare | n/m |
| CCEL Cryo-Cell International Inc. | n/m |
| BTMD biote Corp. compare | 6.6× |
| JYNT The Joint Corp. compare | 25.5× |
| BMGL Basel Medical Group Ltd compare | — |
| Medical Care Facilities industry median | 18.7× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)